1 GLP-1 mainly acts in three ways on glucose and these actions are mediated by the GLP-1 receptors
Muskiet MHA, Tonneijck L, Smits MM, van Baar MJB, Kramer MHH, Hoorn EJ, et al
The strategic bet isnt beat IL-17s on skin clearance its whether an oral with a clean long-term safety profile can win the chronic, convenience-sensitive patient the biologics underserve
Eden vs
Peptide therapy offers a medically supervised way to address the root causes, not just the symptoms
In contrast, the class-level analysis assumes homogeneity across all GLP-1RAs, an assumption that does not always hold given population and pharmacologic differences across studies